Description of the Business (Details) - USD ($) |
6 Months Ended | ||
---|---|---|---|
Sep. 09, 2022 |
Jun. 30, 2023 |
Mar. 31, 2023 |
|
Description of the Business (Details) [Line Items] | |||
Description of shares issued | follows (i) an aggregate of 36,650,778 shares of Common Stock, par value $0.0001 (the “Common Stock” of CLAQ prior to the Closing, and the Common Stock of Nauticus following the Closing) shares were issued to holders of Nauticus Common Stock in the Business Combination (ii) the right to receive 7,499,993 additional shares of Common Stock held in escrow pursuant to the terms of the Merger Agreement and as further described below (such additional escrowed shares, the “Earnout Shares”) and (iii) the issuance of 3,100,000 shares of Common Stock for the Equity Financing (as described below). An aggregate of 47,250,771 shares of Common Stock (inclusive of the Earnout Shares) was issued after the Business Combination. | ||
Additional shares of common stock (in Shares) | 7,499,993 | ||
Merger agreement, description | i.one-half of the Earnout Shares will be released if, within a 5-year period from Closing Date, the volume-weighted average price of our Common Stock equals or exceeds $15.00 per share over any 20 trading days within a 30-day trading period; ii.one-quarter of the Earnout Shares will be released if, within a 5-year period from Closing Date, the volume-weighted average price of our Common Stock equals or exceeds $17.50 per share over any 20 trading days within a 30-day trading period; and iii.one-quarter of the Earnout Shares will be released if, on or after December 31, 2022, within a 5-year period from Closing Date, the volume-weighted average price of our Common Stock equals or exceeds $20.00 per share over any 20 trading days within a 30-day trading period. | ||
Aggregate shares (in Shares) | 3,100,000 | ||
Common stock per share (in Dollars per share) | $ 10 | ||
Total equity financing | $ 31,000,000 | ||
Principal amount | 36,530,320 | ||
Warrants | $ 590,266 | ||
Weighted average per share (in Dollars per share) | $ 3.28 | ||
Exercise shares (in Shares) | 165,713 | ||
Aggregate principal amount | $ 14,947,875 | ||
Prepaid expense | 30,157 | ||
Accounts payable and accrued liabilities | 14,796,942 | $ 3,958,645 | |
Notes payable | 850,333 | ||
Net equity | $ (669,243) | ||
Transaction costs | $ 14,947,875 | ||
Net tangible assets | 12,582,000 | ||
Total cash and cash equivalents | 4,400,000 | ||
SPA Warrants [Member] | |||
Description of the Business (Details) [Line Items] | |||
Warrants | $ 20,949,110 | ||
Exercise Price per share (in Dollars per share) | $ 2 | ||
Convertible debt (in Shares) | 2,922,425 | ||
Additional warrant shares (in Shares) | 2,922,425 | ||
Preferred Stock [Member] | |||
Description of the Business (Details) [Line Items] | |||
Public share price (in Shares) | 0.01 | ||
Common Stock [Member] | |||
Description of the Business (Details) [Line Items] | |||
Common stock per share (in Dollars per share) | $ 20 | ||
New SPA Warrants [Member] | |||
Description of the Business (Details) [Line Items] | |||
Exercise shares (in Shares) | 165,713 | ||
Minimum [Member] | |||
Description of the Business (Details) [Line Items] | |||
Tranches priced per share (in Dollars per share) | $ 2.04 | ||
Maximum [Member] | |||
Description of the Business (Details) [Line Items] | |||
Tranches priced per share (in Dollars per share) | $ 4.64 | ||
Securities purchase agreement [Member] | |||
Description of the Business (Details) [Line Items] | |||
Net proceeds | $ 35,800,000 | ||
Trust Account [Member] | Preferred Stock [Member] | |||
Description of the Business (Details) [Line Items] | |||
Public share price (in Dollars per share) | $ 0.01 |